BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2014-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BP-C1 is effective in the treatment of
metastatic breast cancer patients who had previously received at least three lines of
chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Meabco A/S
Collaborators:
Meddoc Meddoc AS Norwegian University of Life Sciences